This newsletter contains articles on the following subjects:
- Revocation due to lack of inventive step of Pfizer patent on polymorph of magnesium atrovastatin.
- Bad faith, nullity of marks and infringement: Nuances of the CTM Court criteria.
- The defendant’s lack of cooperation cannot benefit him when quantifying the damages.
- Condemnatory Judgment in a criminal case of imitation of a well-known trademark, the importer having invoked a cover registration.